Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LKM
3126
PUT
DELISTED
Link Motion Inc.
LKM
| $2.55M | ﹤0.01% |
668,300
+144,900
| +28% | +$557K |
|
|
TGP
3127
PUT
DELISTED
Teekay LNG Partners L.P.
TGP
| $2.55M | ﹤0.01% |
168,700
+14,100
| +9% | +$177K |
|
3128
CALL
abrdn Physical Gold Shares ETF
SGOL
$7.45B
| $2.55M | ﹤0.01% |
199,000
+174,000
| +696% | +$2.26M |
|
3129
PUT
Columbia Sportswear
COLM
$2.98B
| $2.55M | ﹤0.01% |
44,900
+1,800
| +4% | +$103K |
|
3130
CALL
Republic Services
RSG
$68.1B
| $2.55M | ﹤0.01% |
50,500
-19,900
| -28% | -$1.02M |
|
3131
Corpay
CPAY
$26.8B
| $2.55M | ﹤0.01% |
14,662
+4,675
| +47% | +$749K |
|
|
SCG
3132
CALL
DELISTED
Scana
SCG
| $2.55M | ﹤0.01% |
35,200
-15,800
| -31% | -$1.15M |
|
3133
CALL
Beazer Homes USA
BZH
$887M
| $2.54M | ﹤0.01% |
218,300
+178,400
| +447% | +$1.82M |
|
3134
CALL
iShares Core MSCI Emerging Markets ETF
IEMG
$161B
| $2.54M | ﹤0.01% |
55,800
-68,400
| -55% | -$3.04M |
|
3135
PUT
iShares Core S&P Small-Cap ETF
IJR
$110B
| $2.54M | ﹤0.01% |
41,000
+26,600
| +185% | +$1.62M |
|
3136
CALL
MasTec
MTZ
$19.4B
| $2.54M | ﹤0.01% |
85,500
+24,200
| +39% | +$664K |
|
3137
CALL
Vanda Pharmaceuticals
VNDA
$317M
| $2.54M | ﹤0.01% |
152,800
+88,500
| +138% | +$1.19M |
|
|
KITE
3138
DELISTED
Kite Pharma, Inc.
KITE
| $2.54M | ﹤0.01% |
+45,526
| New | +$2.54M |
|
3139
Kohl's
KSS
$2B
| $2.54M | ﹤0.01% |
+58,100
| New | +$2.43M |
|
3140
CALL
Teradyne
TER
$56.1B
| $2.54M | ﹤0.01% |
117,800
+43,100
| +58% | +$890K |
|
3141
CALL
Carter's
CRI
$1.24B
| $2.54M | ﹤0.01% |
29,300
+20,500
| +233% | +$2.06M |
|
3142
Vanguard Real Estate ETF
VNQ
$38.7B
| $2.54M | ﹤0.01% |
29,292
-15,022
| -34% | -$1.34M |
|
3143
Banco Santander Chile
BSAC
$16.6B
| $2.54M | ﹤0.01% |
122,570
+95,570
| +354% | +$2M |
|
3144
Ralph Lauren
RL
$21.1B
| $2.54M | ﹤0.01% |
25,065
-48,916
| -66% | -$4.91M |
|
|
3145
Vanda Pharmaceuticals
VNDA
$317M
| $2.53M | ﹤0.01% |
152,299
+34,786
| +30% | +$468K |
|
|
MATF
3146
DELISTED
iShares Edge MSCI Multifactor Materials ETF
MATF
| $2.53M | ﹤0.01% |
96,516
-1,282
| -1% | -$33.9K |
|
|
SSRI
3147
CALL
DELISTED
Silver Standard Resources
SSRI
| $2.53M | ﹤0.01% |
210,000
-21,600
| -9% | -$291K |
|
3148
First Trust Health Care AlphaDEX Fund
FXH
$1.15B
| $2.53M | ﹤0.01% |
41,614
-11,490
| -22% | -$699K |
|
3149
First Trust Consumer Staples AlphaDEX Fund
FXG
$232M
| $2.53M | ﹤0.01% |
54,456
+40,149
| +281% | +$1.93M |
|
3150
PUT
EQT Corp
EQT
$34.1B
| $2.53M | ﹤0.01% |
63,928
+9,002
| +16% | +$356K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.